The difficulties of working with radiotracers

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

Initial results of inhibitor combination against breast and gynaecologic cancers

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection

The role of tumour marker testing in early diagnosis

The METRIC trial of trametinib, five years on

Treatment choices in thyroid cancer

RANGE trial of ramucirumab for urothelial cancer

Small node-negative breast cancers may retain aggressive characteristics

Adaptive TONIC trial of nivolumab combinations for breast cancer

Panitumumab triplet therapy in colorectal cancer

Long term efficacy of denosumab for giant cell bone tumours